0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Breathing Disorders & Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-12Q7067
Home | Market Reports | Health| Health Conditions
Global Breathing Disorders Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Breathing Disorders & Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-12Q7067
Report
September 2024
Pages:154
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Breathing Disorders & Treatment - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Breathing Disorders & Treatment - Market

Breathing Disorders & Treatment - Market

The respiratory therapy area consists of indications that affect the respiratory system in different ways, such as the scarring of lung tissue, and excessive production of mucus in the airways, thereby decreasing lung function. Some of the key indications in this therapy area include asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and idiopathic pulmonary fibrosis (IPF). The causes of respiratory disorders vary significantly across each indication, and include factors such as environment, occupation, genetic predisposition and aging.
The global market for Breathing Disorders & Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Breathing Disorders & Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Breathing Disorders & Treatment by region & country, by Type, and by Application.
The Breathing Disorders & Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breathing Disorders & Treatment.
Market Segmentation

Scope of Breathing Disorders & Treatment - Market Report

Report Metric Details
Report Name Breathing Disorders & Treatment - Market
CAGR 5%
Segment by Type:
Segment by Application
  • Hospital
  • Clinics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca, Boehringer, GSK, Merck, Roche, Novartis, Abbott, Actavis, Afferent Pharmaceuticals, Almirall, Amgen, AptarGroup, Astellas, Aurobindo, Axis-Shield, Baxter, Bayer, Biogen, Biotest, Bristol-Myers Squibb, Chiesi Farmaceutici, Cipla, Cytos, Dainippon Sumitomo, Dr. Reddy's Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Breathing Disorders & Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Breathing Disorders & Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Breathing Disorders & Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Breathing Disorders & Treatment - Market report?

Ans: The main players in the Breathing Disorders & Treatment - Market are AstraZeneca, Boehringer, GSK, Merck, Roche, Novartis, Abbott, Actavis, Afferent Pharmaceuticals, Almirall, Amgen, AptarGroup, Astellas, Aurobindo, Axis-Shield, Baxter, Bayer, Biogen, Biotest, Bristol-Myers Squibb, Chiesi Farmaceutici, Cipla, Cytos, Dainippon Sumitomo, Dr. Reddy's Laboratories

What are the Application segmentation covered in the Breathing Disorders & Treatment - Market report?

Ans: The Applications covered in the Breathing Disorders & Treatment - Market report are Hospital, Clinics, Other

What are the Type segmentation covered in the Breathing Disorders & Treatment - Market report?

Ans: The Types covered in the Breathing Disorders & Treatment - Market report are Asthma, COPD, Allergic Rhinitis, Pulmonary Hypertension, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis

Recommended Reports

Respiratory Drug Treatment

Respiratory Devices Market

Sleep & Oxygen Therapy

1 Market Overview
1.1 Breathing Disorders & Treatment Product Introduction
1.2 Global Breathing Disorders & Treatment Market Size Forecast
1.3 Breathing Disorders & Treatment Market Trends & Drivers
1.3.1 Breathing Disorders & Treatment Industry Trends
1.3.2 Breathing Disorders & Treatment Market Drivers & Opportunity
1.3.3 Breathing Disorders & Treatment Market Challenges
1.3.4 Breathing Disorders & Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Breathing Disorders & Treatment Players Revenue Ranking (2023)
2.2 Global Breathing Disorders & Treatment Revenue by Company (2019-2024)
2.3 Key Companies Breathing Disorders & Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Breathing Disorders & Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Breathing Disorders & Treatment
2.6 Breathing Disorders & Treatment Market Competitive Analysis
2.6.1 Breathing Disorders & Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Breathing Disorders & Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breathing Disorders & Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Asthma
3.1.2 COPD
3.1.3 Allergic Rhinitis
3.1.4 Pulmonary Hypertension
3.1.5 Cystic Fibrosis
3.1.6 Idiopathic Pulmonary Fibrosis
3.2 Global Breathing Disorders & Treatment Sales Value by Type
3.2.1 Global Breathing Disorders & Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Breathing Disorders & Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Breathing Disorders & Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinics
4.1.3 Other
4.2 Global Breathing Disorders & Treatment Sales Value by Application
4.2.1 Global Breathing Disorders & Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Breathing Disorders & Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Breathing Disorders & Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Breathing Disorders & Treatment Sales Value by Region
5.1.1 Global Breathing Disorders & Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Breathing Disorders & Treatment Sales Value by Region (2019-2024)
5.1.3 Global Breathing Disorders & Treatment Sales Value by Region (2025-2030)
5.1.4 Global Breathing Disorders & Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Breathing Disorders & Treatment Sales Value, 2019-2030
5.2.2 North America Breathing Disorders & Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Breathing Disorders & Treatment Sales Value, 2019-2030
5.3.2 Europe Breathing Disorders & Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Breathing Disorders & Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Breathing Disorders & Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Breathing Disorders & Treatment Sales Value, 2019-2030
5.5.2 South America Breathing Disorders & Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Breathing Disorders & Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Breathing Disorders & Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Breathing Disorders & Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Breathing Disorders & Treatment Sales Value
6.3 United States
6.3.1 United States Breathing Disorders & Treatment Sales Value, 2019-2030
6.3.2 United States Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Breathing Disorders & Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Breathing Disorders & Treatment Sales Value, 2019-2030
6.4.2 Europe Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Breathing Disorders & Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Breathing Disorders & Treatment Sales Value, 2019-2030
6.5.2 China Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Breathing Disorders & Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Breathing Disorders & Treatment Sales Value, 2019-2030
6.6.2 Japan Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Breathing Disorders & Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Breathing Disorders & Treatment Sales Value, 2019-2030
6.7.2 South Korea Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Breathing Disorders & Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Breathing Disorders & Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Breathing Disorders & Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Breathing Disorders & Treatment Sales Value, 2019-2030
6.9.2 India Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Breathing Disorders & Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Profile
7.1.2 AstraZeneca Main Business
7.1.3 AstraZeneca Breathing Disorders & Treatment Products, Services and Solutions
7.1.4 AstraZeneca Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 AstraZeneca Recent Developments
7.2 Boehringer
7.2.1 Boehringer Profile
7.2.2 Boehringer Main Business
7.2.3 Boehringer Breathing Disorders & Treatment Products, Services and Solutions
7.2.4 Boehringer Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Boehringer Recent Developments
7.3 GSK
7.3.1 GSK Profile
7.3.2 GSK Main Business
7.3.3 GSK Breathing Disorders & Treatment Products, Services and Solutions
7.3.4 GSK Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Merck Recent Developments
7.4 Merck
7.4.1 Merck Profile
7.4.2 Merck Main Business
7.4.3 Merck Breathing Disorders & Treatment Products, Services and Solutions
7.4.4 Merck Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Merck Recent Developments
7.5 Roche
7.5.1 Roche Profile
7.5.2 Roche Main Business
7.5.3 Roche Breathing Disorders & Treatment Products, Services and Solutions
7.5.4 Roche Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Recent Developments
7.6 Novartis
7.6.1 Novartis Profile
7.6.2 Novartis Main Business
7.6.3 Novartis Breathing Disorders & Treatment Products, Services and Solutions
7.6.4 Novartis Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Novartis Recent Developments
7.7 Abbott
7.7.1 Abbott Profile
7.7.2 Abbott Main Business
7.7.3 Abbott Breathing Disorders & Treatment Products, Services and Solutions
7.7.4 Abbott Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Abbott Recent Developments
7.8 Actavis
7.8.1 Actavis Profile
7.8.2 Actavis Main Business
7.8.3 Actavis Breathing Disorders & Treatment Products, Services and Solutions
7.8.4 Actavis Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Actavis Recent Developments
7.9 Afferent Pharmaceuticals
7.9.1 Afferent Pharmaceuticals Profile
7.9.2 Afferent Pharmaceuticals Main Business
7.9.3 Afferent Pharmaceuticals Breathing Disorders & Treatment Products, Services and Solutions
7.9.4 Afferent Pharmaceuticals Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Afferent Pharmaceuticals Recent Developments
7.10 Abbott
7.10.1 Abbott Profile
7.10.2 Abbott Main Business
7.10.3 Abbott Breathing Disorders & Treatment Products, Services and Solutions
7.10.4 Abbott Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Abbott Recent Developments
7.11 Almirall
7.11.1 Almirall Profile
7.11.2 Almirall Main Business
7.11.3 Almirall Breathing Disorders & Treatment Products, Services and Solutions
7.11.4 Almirall Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Almirall Recent Developments
7.12 Amgen
7.12.1 Amgen Profile
7.12.2 Amgen Main Business
7.12.3 Amgen Breathing Disorders & Treatment Products, Services and Solutions
7.12.4 Amgen Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Amgen Recent Developments
7.13 AptarGroup
7.13.1 AptarGroup Profile
7.13.2 AptarGroup Main Business
7.13.3 AptarGroup Breathing Disorders & Treatment Products, Services and Solutions
7.13.4 AptarGroup Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 AptarGroup Recent Developments
7.14 Astellas
7.14.1 Astellas Profile
7.14.2 Astellas Main Business
7.14.3 Astellas Breathing Disorders & Treatment Products, Services and Solutions
7.14.4 Astellas Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 Astellas Recent Developments
7.15 Aurobindo
7.15.1 Aurobindo Profile
7.15.2 Aurobindo Main Business
7.15.3 Aurobindo Breathing Disorders & Treatment Products, Services and Solutions
7.15.4 Aurobindo Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.15.5 Aurobindo Recent Developments
7.16 Axis-Shield
7.16.1 Axis-Shield Profile
7.16.2 Axis-Shield Main Business
7.16.3 Axis-Shield Breathing Disorders & Treatment Products, Services and Solutions
7.16.4 Axis-Shield Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.16.5 Axis-Shield Recent Developments
7.17 Baxter
7.17.1 Baxter Profile
7.17.2 Baxter Main Business
7.17.3 Baxter Breathing Disorders & Treatment Products, Services and Solutions
7.17.4 Baxter Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.17.5 Baxter Recent Developments
7.18 Bayer
7.18.1 Bayer Profile
7.18.2 Bayer Main Business
7.18.3 Bayer Breathing Disorders & Treatment Products, Services and Solutions
7.18.4 Bayer Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.18.5 Bayer Recent Developments
7.19 Biogen
7.19.1 Biogen Profile
7.19.2 Biogen Main Business
7.19.3 Biogen Breathing Disorders & Treatment Products, Services and Solutions
7.19.4 Biogen Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.19.5 Biogen Recent Developments
7.20 Biotest
7.20.1 Biotest Profile
7.20.2 Biotest Main Business
7.20.3 Biotest Breathing Disorders & Treatment Products, Services and Solutions
7.20.4 Biotest Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.20.5 Biotest Recent Developments
7.21 Bristol-Myers Squibb
7.21.1 Bristol-Myers Squibb Profile
7.21.2 Bristol-Myers Squibb Main Business
7.21.3 Bristol-Myers Squibb Breathing Disorders & Treatment Products, Services and Solutions
7.21.4 Bristol-Myers Squibb Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.21.5 Bristol-Myers Squibb Recent Developments
7.22 Chiesi Farmaceutici
7.22.1 Chiesi Farmaceutici Profile
7.22.2 Chiesi Farmaceutici Main Business
7.22.3 Chiesi Farmaceutici Breathing Disorders & Treatment Products, Services and Solutions
7.22.4 Chiesi Farmaceutici Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.22.5 Chiesi Farmaceutici Recent Developments
7.23 Cipla
7.23.1 Cipla Profile
7.23.2 Cipla Main Business
7.23.3 Cipla Breathing Disorders & Treatment Products, Services and Solutions
7.23.4 Cipla Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.23.5 Cipla Recent Developments
7.24 Cytos
7.24.1 Cytos Profile
7.24.2 Cytos Main Business
7.24.3 Cytos Breathing Disorders & Treatment Products, Services and Solutions
7.24.4 Cytos Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.24.5 Cytos Recent Developments
7.25 Dainippon Sumitomo
7.25.1 Dainippon Sumitomo Profile
7.25.2 Dainippon Sumitomo Main Business
7.25.3 Dainippon Sumitomo Breathing Disorders & Treatment Products, Services and Solutions
7.25.4 Dainippon Sumitomo Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.25.5 Dainippon Sumitomo Recent Developments
7.26 Dr. Reddy's Laboratories
7.26.1 Dr. Reddy's Laboratories Profile
7.26.2 Dr. Reddy's Laboratories Main Business
7.26.3 Dr. Reddy's Laboratories Breathing Disorders & Treatment Products, Services and Solutions
7.26.4 Dr. Reddy's Laboratories Breathing Disorders & Treatment Revenue (US$ Million) & (2019-2024)
7.26.5 Dr. Reddy's Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Breathing Disorders & Treatment Industrial Chain
8.2 Breathing Disorders & Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Breathing Disorders & Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Breathing Disorders & Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Breathing Disorders & Treatment Market Trends
    Table 2. Breathing Disorders & Treatment Market Drivers & Opportunity
    Table 3. Breathing Disorders & Treatment Market Challenges
    Table 4. Breathing Disorders & Treatment Market Restraints
    Table 5. Global Breathing Disorders & Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Breathing Disorders & Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Breathing Disorders & Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Breathing Disorders & Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Breathing Disorders & Treatment
    Table 10. Global Breathing Disorders & Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breathing Disorders & Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Breathing Disorders & Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Breathing Disorders & Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Breathing Disorders & Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Breathing Disorders & Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Breathing Disorders & Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Breathing Disorders & Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Breathing Disorders & Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Breathing Disorders & Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Breathing Disorders & Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Breathing Disorders & Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Breathing Disorders & Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Breathing Disorders & Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Breathing Disorders & Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Breathing Disorders & Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Breathing Disorders & Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Breathing Disorders & Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Breathing Disorders & Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Breathing Disorders & Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. AstraZeneca Basic Information List
    Table 32. AstraZeneca Description and Business Overview
    Table 33. AstraZeneca Breathing Disorders & Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Breathing Disorders & Treatment Business of AstraZeneca (2019-2024)
    Table 35. AstraZeneca Recent Developments
    Table 36. Boehringer Basic Information List
    Table 37. Boehringer Description and Business Overview
    Table 38. Boehringer Breathing Disorders & Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Boehringer (2019-2024)
    Table 40. Boehringer Recent Developments
    Table 41. GSK Basic Information List
    Table 42. GSK Description and Business Overview
    Table 43. GSK Breathing Disorders & Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Breathing Disorders & Treatment Business of GSK (2019-2024)
    Table 45. GSK Recent Developments
    Table 46. Merck Basic Information List
    Table 47. Merck Description and Business Overview
    Table 48. Merck Breathing Disorders & Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Merck (2019-2024)
    Table 50. Merck Recent Developments
    Table 51. Roche Basic Information List
    Table 52. Roche Description and Business Overview
    Table 53. Roche Breathing Disorders & Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Roche (2019-2024)
    Table 55. Roche Recent Developments
    Table 56. Novartis Basic Information List
    Table 57. Novartis Description and Business Overview
    Table 58. Novartis Breathing Disorders & Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Novartis (2019-2024)
    Table 60. Novartis Recent Developments
    Table 61. Abbott Basic Information List
    Table 62. Abbott Description and Business Overview
    Table 63. Abbott Breathing Disorders & Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Abbott (2019-2024)
    Table 65. Abbott Recent Developments
    Table 66. Actavis Basic Information List
    Table 67. Actavis Description and Business Overview
    Table 68. Actavis Breathing Disorders & Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Actavis (2019-2024)
    Table 70. Actavis Recent Developments
    Table 71. Afferent Pharmaceuticals Basic Information List
    Table 72. Afferent Pharmaceuticals Description and Business Overview
    Table 73. Afferent Pharmaceuticals Breathing Disorders & Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Afferent Pharmaceuticals (2019-2024)
    Table 75. Afferent Pharmaceuticals Recent Developments
    Table 76. Abbott Basic Information List
    Table 77. Abbott Description and Business Overview
    Table 78. Abbott Breathing Disorders & Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Abbott (2019-2024)
    Table 80. Abbott Recent Developments
    Table 81. Almirall Basic Information List
    Table 82. Almirall Description and Business Overview
    Table 83. Almirall Breathing Disorders & Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Almirall (2019-2024)
    Table 85. Almirall Recent Developments
    Table 86. Amgen Basic Information List
    Table 87. Amgen Description and Business Overview
    Table 88. Amgen Breathing Disorders & Treatment Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Amgen (2019-2024)
    Table 90. Amgen Recent Developments
    Table 91. AptarGroup Basic Information List
    Table 92. AptarGroup Description and Business Overview
    Table 93. AptarGroup Breathing Disorders & Treatment Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Breathing Disorders & Treatment Business of AptarGroup (2019-2024)
    Table 95. AptarGroup Recent Developments
    Table 96. Astellas Basic Information List
    Table 97. Astellas Description and Business Overview
    Table 98. Astellas Breathing Disorders & Treatment Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Astellas (2019-2024)
    Table 100. Astellas Recent Developments
    Table 101. Aurobindo Basic Information List
    Table 102. Aurobindo Description and Business Overview
    Table 103. Aurobindo Breathing Disorders & Treatment Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Aurobindo (2019-2024)
    Table 105. Aurobindo Recent Developments
    Table 106. Axis-Shield Basic Information List
    Table 107. Axis-Shield Description and Business Overview
    Table 108. Axis-Shield Breathing Disorders & Treatment Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Axis-Shield (2019-2024)
    Table 110. Axis-Shield Recent Developments
    Table 111. Baxter Basic Information List
    Table 112. Baxter Description and Business Overview
    Table 113. Baxter Breathing Disorders & Treatment Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Baxter (2019-2024)
    Table 115. Baxter Recent Developments
    Table 116. Bayer Basic Information List
    Table 117. Bayer Description and Business Overview
    Table 118. Bayer Breathing Disorders & Treatment Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Bayer (2019-2024)
    Table 120. Bayer Recent Developments
    Table 121. Biogen Basic Information List
    Table 122. Biogen Description and Business Overview
    Table 123. Biogen Breathing Disorders & Treatment Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Biogen (2019-2024)
    Table 125. Biogen Recent Developments
    Table 126. Biotest Basic Information List
    Table 127. Biotest Description and Business Overview
    Table 128. Biotest Breathing Disorders & Treatment Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Biotest (2019-2024)
    Table 130. Biotest Recent Developments
    Table 131. Bristol-Myers Squibb Basic Information List
    Table 132. Bristol-Myers Squibb Description and Business Overview
    Table 133. Bristol-Myers Squibb Breathing Disorders & Treatment Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Bristol-Myers Squibb (2019-2024)
    Table 135. Bristol-Myers Squibb Recent Developments
    Table 136. Chiesi Farmaceutici Basic Information List
    Table 137. Chiesi Farmaceutici Description and Business Overview
    Table 138. Chiesi Farmaceutici Breathing Disorders & Treatment Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Chiesi Farmaceutici (2019-2024)
    Table 140. Chiesi Farmaceutici Recent Developments
    Table 141. Cipla Basic Information List
    Table 142. Cipla Description and Business Overview
    Table 143. Cipla Breathing Disorders & Treatment Products, Services and Solutions
    Table 144. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Cipla (2019-2024)
    Table 145. Cipla Recent Developments
    Table 146. Cytos Basic Information List
    Table 147. Cytos Description and Business Overview
    Table 148. Cytos Breathing Disorders & Treatment Products, Services and Solutions
    Table 149. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Cytos (2019-2024)
    Table 150. Cytos Recent Developments
    Table 151. Dainippon Sumitomo Basic Information List
    Table 152. Dainippon Sumitomo Description and Business Overview
    Table 153. Dainippon Sumitomo Breathing Disorders & Treatment Products, Services and Solutions
    Table 154. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Dainippon Sumitomo (2019-2024)
    Table 155. Dainippon Sumitomo Recent Developments
    Table 156. Dr. Reddy's Laboratories Basic Information List
    Table 157. Dr. Reddy's Laboratories Description and Business Overview
    Table 158. Dr. Reddy's Laboratories Breathing Disorders & Treatment Products, Services and Solutions
    Table 159. Revenue (US$ Million) in Breathing Disorders & Treatment Business of Dr. Reddy's Laboratories (2019-2024)
    Table 160. Dr. Reddy's Laboratories Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. Breathing Disorders & Treatment Downstream Customers
    Table 164. Breathing Disorders & Treatment Distributors List
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
    Table 168. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Breathing Disorders & Treatment Product Picture
    Figure 2. Global Breathing Disorders & Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Breathing Disorders & Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Breathing Disorders & Treatment Report Years Considered
    Figure 5. Global Breathing Disorders & Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Breathing Disorders & Treatment Revenue in 2023
    Figure 7. Breathing Disorders & Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Asthma Picture
    Figure 9. COPD Picture
    Figure 10. Allergic Rhinitis Picture
    Figure 11. Pulmonary Hypertension Picture
    Figure 12. Cystic Fibrosis Picture
    Figure 13. Idiopathic Pulmonary Fibrosis Picture
    Figure 14. Global Breathing Disorders & Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Breathing Disorders & Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Hospital
    Figure 17. Product Picture of Clinics
    Figure 18. Product Picture of Other
    Figure 19. Global Breathing Disorders & Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Breathing Disorders & Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Breathing Disorders & Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Breathing Disorders & Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Breathing Disorders & Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Breathing Disorders & Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Breathing Disorders & Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Breathing Disorders & Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Breathing Disorders & Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Breathing Disorders & Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Breathing Disorders & Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Breathing Disorders & Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Breathing Disorders & Treatment Sales Value (%), (2019-2030)
    Figure 32. United States Breathing Disorders & Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Breathing Disorders & Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Breathing Disorders & Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Breathing Disorders & Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Breathing Disorders & Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Breathing Disorders & Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Breathing Disorders & Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Breathing Disorders & Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Breathing Disorders & Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Breathing Disorders & Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Breathing Disorders & Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Breathing Disorders & Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Breathing Disorders & Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Breathing Disorders & Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Breathing Disorders & Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 53. Breathing Disorders & Treatment Industrial Chain
    Figure 54. Breathing Disorders & Treatment Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS